# Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis

> **NCT01261624** · PHASE2 · TERMINATED · sponsor: **Italfarmaco** · enrollment: 16 (actual)

## Conditions studied

- Polyarticular Course Juvenile Idiopathic Arthritis

## Interventions

- **DRUG:** Givinostat

## Key facts

- **NCT ID:** NCT01261624
- **Lead sponsor:** Italfarmaco
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2012-06
- **Final completion:** 2013-03
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** The primary reason for the decision to discontinue the study is lack of enrolment; this decision is not related to any tolerability concerns with Givinostat
- **Last updated:** 2014-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01261624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01261624, "Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01261624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*